Skip to main content
Watch Insiders
NBIXHealthcare

Neurocrine Biosciences, Inc. (NBIX) Insider Trading

In the last 90 days, 3 Neurocrine Biosciences, Inc. (NBIX) insiders reported no open-market purchases and 3 sales totaling $826,365. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 14, 2026David W. BoyerChief Corp. Affairs OfficerSale826$157.45$130,051
Sep 14, 2026Matt AbernethyChief Financial OfficerSale2,311$157.20$363,285
Sep 9, 2026Eric BenevichChief Commercial OfficerSale2,154$154.61$333,030
Jul 28, 2026Leslie V NorwalkCorporate insiderSale1,250$182.01$227,508
Jul 10, 2026Ingrid DelaetChief Regulatory OfficerSale4,367$181.02$790,514
Jul 9, 2026Ingrid DelaetChief Regulatory OfficerSale14,571$178.65$2,603,112
Jul 9, 2026Darin LippoldtChief Legal OfficerSale10,000$179.60$1,796,014
Jun 29, 2026Darin LippoldtChief Legal OfficerSale10,000$170.15$1,701,492
Jun 5, 2026Stephen A SherwinCorporate insiderSale25,000$165.32$4,132,970
Jun 4, 2026Leslie V NorwalkCorporate insiderSale1,250$168.06$210,072
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

NBIX insider trading FAQ

Are NBIX insiders buying or selling?
Over the last 90 days, NBIX insiders were net sellers, reporting $0.00 of open-market purchases and $826,365 of sales.
When was the last NBIX insider purchase?
No open-market insider purchase of Neurocrine Biosciences, Inc. stock was reported in the last 90 days.
Where does NBIX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Neurocrine Biosciences, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.